Sidewinder Therapeutics
PrivateLast Round
Series B
Apr 8, 2026
Total Funding Raised
$162M
Momentum Score
50 /100
Company Overview
Sidewinder Therapeutics is a biopharmaceutical company that develops next-generation bispecific antibody-drug conjugates (ADCs) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sidewinder Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Sidewinder Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 8, 2026 | ||||
| Series A | Oct 25, 2023 |
Key People
Founding team and executive leadership
Sidewinder Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series B |
| Life Sciences at Goldman Sachs Alternatives | Series B |
| OrbiMed | Series B, Series A |
| Novartis Venture Fund | Series B |
| Frazier Life Sciences | Series B |
| Alexandria Venture Investments | Series B |
| Astellas Venture Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
$137M round raised.
- Nov 26, 2024
Grew 30% QoQ, from 10 to 13 employees.
Sidewinder Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sidewinder Therapeutics's valuation, stock price, and market status.
